Other names: RGS-17, RGSZ2, hRGS17 HGNC (Hugo): RGS17 Location: 6q25.2
DNA/RNA

Description
The RGS17 gene spans over a region of 120 kbp DNA including 4 coding exons and 1 non-coding exon (exon 1).
Transcription
The RGS17 gene mRNA consists of about 1472 nucleotides with an open reading frame (ORF) of 633 bases.
Pseudogene
RGS17P1 regulator of G-protein signaling 17 pseudogene 1.
Protein
Note 210 amino acids; 24 kDa.
Description
The RGS17 protein consists of 210 amino acid residues. This gene encodes a member of the regulator of G-protein signaling family. This protein contains a conserved, 120 amino acid motif called the RGS domain and a cysteine-rich region.
Expression
Widely expressed in human organs.
Localisation
Its cellular localization has not been formally monitored to date.
Function
The protein attenuates the signaling activity of Gproteins by binding to activated, GTP-bound G alpha subunits and acting as a GTPase activating protein (GAP), increasing the rate of conversion of the GTP to GDP. RGS proteins are GTPase-activating proteins for Gi and Gq class G-alpha proteins. They accelerate transit through the cycle of GTP binding and hydrolysis and thereby accelerate signaling kinetics and termination. This hydrolysis allows the G alpha subunits to bind G beta/gamma subunit heterodimers, forming inactive G-protein heterotrimers, thereby terminating the signal.
Homology
The RGS17 gene is conserved in chimpanzee, dog, cow, mouse, rat, chicken, and zebrafish.
Mutations
Germinal
No germline mutations in this gene have been reported.
Somatic
A synonymous-coding somatic mutations of this gene is reported in pancreas cancer at codon 166, P166P (COSMIC).
Implicated in
Various cancer
Note Lung cancer, prostate cancer. Disease RSG17 is overexpressed in lung and prostate cancer . Expression of RGS17 is upregulated in 80% of lung tumors, and also up-regulated in prostate tumors. Overexpression of RGS17 induce and maintain cell proliferation.
Lung cancer
Disease hsa-mir-182 is involved in the down regulation of RGS17 expression through two conserved sites located in its 3' UTR region (Sun et al., 2010) . Two SNPs in the first intron of RGS17 (rs4083914 and rs9479510) were found associated with familial lung cancer susceptibility ).
Ovarian cancer
Disease RGS2, RGS5, RGS10 and RGS17 transcripts are expressed at significantly lower levels in cells resistant to chemotherapy compared with parental, chemosensitive cells in ovarian cancer cells (Hooks et al., 2010) . Prognosis RGS17 loss of expression contributes to the development of chemoresistance in ovarian cancer cells.
